GLUD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.42659275690494E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.39410002933482E-09 |
Normal-vs-Stage2 |
7.50949999961392E-07 |
Normal-vs-Stage3 |
6.81454892514921E-13 |
Normal-vs-Stage4 |
1.64079860809352E-12 |
Stage1-vs-Stage2 |
7.374200E-01 |
Stage1-vs-Stage3 |
6.497800E-03 |
Stage1-vs-Stage4 |
1.383700E-03 |
Stage2-vs-Stage3 |
1.152030E-01 |
Stage2-vs-Stage4 |
2.766400E-02 |
Stage3-vs-Stage4 |
4.868600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.84618986764917E-12 |
Normal-vs-AfricanAmerican |
3.12339998309596E-09 |
Normal-vs-Asian |
7.459100E-03 |
Caucasian-vs-AfricanAmerican |
1.455800E-01 |
Caucasian-vs-Asian |
9.640400E-01 |
AfricanAmerican-vs-Asian |
6.450600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
2.1197999999778E-06 |
Male-vs-Female |
2.54939999999593E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.225500E-04 |
Normal-vs-Age(41-60Yrs) |
1.81350490180421E-11 |
Normal-vs-Age(61-80Yrs) |
2.49589238165981E-12 |
Normal-vs-Age(81-100Yrs) |
2.0321999999906E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.019800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.327800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.351200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.998600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.254200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.033200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.497770E-03 |
Normal-vs-Grade 2 |
2.10229999964007E-07 |
Normal-vs-Grade 3 |
1.66533453693773E-12 |
Normal-vs-Grade 4 |
<1E-12 |
Grade 1-vs-Grade 2 |
5.864800E-01 |
Grade 1-vs-Grade 3 |
5.375200E-01 |
Grade 1-vs-Grade 4 |
7.197800E-03 |
Grade 2-vs-Grade 3 |
6.855900E-03 |
Grade 2-vs-Grade 4 |
2.92760005127235E-09 |
Grade 3-vs-Grade 4 |
2.987100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.13519999999945E-05 |
Normal-vs-ccB subtype |
1.62658775337832E-12 |
ccA subtype-vs-ccB subtype |
8.9123999957863E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.11479999570707E-08 |
Normal-vs-N1 |
1.62056999999383E-05 |
N0-vs-N1 |
2.093400E-01 |
|
|